Luis Borrero-Garcia

Director of Research & Development at MBQ Pharma - San Juan, San Juan, Puerto Rico

Luis Borrero-Garcia's Colleagues at MBQ Pharma
Luis Borrero-Garcia's Contact Details
HQ
Location
Puerto Rico
Company
MBQ Pharma
Luis Borrero-Garcia's Company Details
MBQ Pharma logo, MBQ Pharma contact details

MBQ Pharma

San Juan, San Juan, Puerto Rico • 4 Employees
Pharmaceuticals

MBQ-Pharma targets Rac and CDC42 as key targets for tumor growth inhibition and removal of pre-existing metastasis. MBQ-167 is a first-in-class nanomolar IC50 inhibitor for Rac and CDC42 and has been shown in mouse tumor models to inhibit tumor growth and to reverse advanced metastasis. MBQ-167 has also been shown to have no toxicity findings in rats and dogs through GLP studies and in Safety Pharmacology studies. The IND for MBQ-167 is scheduled by the end of 2021.

Details about MBQ Pharma
Frequently Asked Questions about Luis Borrero-Garcia
Luis Borrero-Garcia currently works for MBQ Pharma.
Luis Borrero-Garcia's role at MBQ Pharma is Director of Research & Development.
Luis Borrero-Garcia's email address is ***@mbqpharma.com. To view Luis Borrero-Garcia's full email address, please signup to ConnectPlex.
Luis Borrero-Garcia works in the Pharmaceuticals industry.
Luis Borrero-Garcia's colleagues at MBQ Pharma are Jean Baez and others.
Luis Borrero-Garcia's phone number is
See more information about Luis Borrero-Garcia